中国实时基于风险的临床试验质量管理:开发数字监测平台

Min Jiang1, Shuhua Zhao2, Yun Mei3

  • 1State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, National Drug Clinical Trial Center, Peking University Cancer Hospital & Institute, 52 Fucheng Rd, Haidian District, Beijing, China, 86 01088196664.

PubMed
概括

一个新的数字平台使用大数据和人工智能来监测中国的临床试验质量,减少错误并提高准确性. 这种自动化系统可以实时检测风险,提高药物评估的效率和患者安全.